• Ilona Telefus Goldfarb
  • Elana Jaffe
  • Kaitlyn James
  • Anne Drapkin Lyerly
2018
Vaccine 36 (45) : 6711-6717
Full article
As Zika virus infection during pregnancy can cause a range of congenital anomalies, pregnant women may be a target population for vaccination in future outbreaks. Their inclusion in vaccine trials is critical to ensure safe and effective vaccines in pregnancy. Though many vaccine candidates are in development, pregnant women’s willingness to participate in Zika virus vaccine research is unknown. This study aims to describe pregnant women’s attitudes toward Zika virus vaccine research participation, as well as perceived barriers to and facilitators of enrollment.